U.S. Court Revives Lawsuit Over Drugmakers’ Overcharge Claims - Global Banking & Finance Review®
A federal appeals court has revived a whistleblower-led False Claims Act suit alleging AbbVie, AstraZeneca, Novartis and Sanofi overcharged Medicare and Medicaid through 340B “penny pricing” viola...